Related Experiment Video
Updated: Aug 21, 2026

Adipose-Derived Mesenchymal Stromal Cells Co-Cultured with Primary Mixed Glia to Reduce Prion-Induced Inflammation
Published on: August 11, 2023
Pathological prion protein exposure switches on neuronal mitogen-activated protein kinase pathway resulting in
Mathieu Marella1, Cédric Gaggioli, Michèle Batoz
1Institut de Pharmacologie Moléculaire et Cellulaire, Unité Mixte de Recherche 6097, Centre National de la Recherche Scientifique 660, route des lucioles, 06560 Valbonne, France.
Abstract:
Transmissible spongiform encephalopathies are accompanied by the recruitment of microglial cells in the vicinity of amyloid aggregates of the pathological prion protein (PrPres). We previously showed that PrPres itself triggered the recruitment of microglia by interacting with neurons leading to the up-regulation of the expression level of chemokines, mainly RANTES (regulated on activation normal T cell expressed and secreted). The intracellular mechanisms underlying the PrPres-inducible expression of chemokines in this setting are not clear. Here we demonstrate that the mitogen-activated protein kinase pathway is switched on shortly after PrPres exposure to neurons leading to the expression of early growth response factor-1 (Egr-1), a transcription factor initially linked to differentiation and growth and to up-regulation of RANTES mRNA expression. PD98059, a selective inhibitor of extracellular signal-regulated kinase1/2 activation, resulted in a decrease of RANTES mRNA expression and as a consequence to the lowering of microglial cell migration. Neuronal overexpression of Nab2, a corepressor of Egr-1, produced similar effects. PrPres-induced chemoattraction is independent of the presence of PrPc and the laminin receptor on the neuronal cell surface. Our report is the first demonstration that PrPres exposure on neurons results in the activation of the MAP kinase signaling pathway that acts as a master switch to trigger neuronal expression of regulators of chemoattraction.
Insights
Pathological prion protein (PrPres) triggers microglial cell recruitment by activating the mitogen-activated protein kinase pathway in neurons. This pathway up-regulates chemokines, influencing prion disease progression.
Area of Science:
- Neuroscience
- Immunology
- Prion Diseases
Background:
- Transmissible spongiform encephalopathies involve microglial cell recruitment near pathological prion protein (PrPres) aggregates.
- PrPres interaction with neurons up-regulates chemokines like RANTES, but intracellular mechanisms remain unclear.
Purpose of the Study:
- To elucidate the intracellular mechanisms of PrPres-induced chemokine expression in neurons.
- To investigate the role of the mitogen-activated protein kinase (MAPK) pathway in this process.
Main Methods:
- Neuronal exposure to PrPres.
- Analysis of MAPK pathway activation and transcription factor Egr-1 expression.
- Inhibition of MAPK pathway using PD98059.
- Neuronal overexpression of Nab2, an Egr-1 corepressor.
Main Results:
- PrPres exposure activates the MAPK pathway in neurons, leading to Early Growth Response factor-1 (Egr-1) expression.
- MAPK pathway activation up-regulates RANTES mRNA expression.
- Inhibition of MAPK signaling or Nab2 overexpression reduced RANTES expression and microglial migration.
- PrPres-induced chemoattraction is independent of PrPc and laminin receptor.
Conclusions:
- The MAPK signaling pathway acts as a master switch for neuronal expression of chemoattraction regulators in response to PrPres.
- This finding clarifies a key mechanism in prion disease pathogenesis and neuroinflammation.
More Related Videos
Related Concept Videos
Encephalitis ll: Pathophysiology
Parkinson Disease ll: Pathophysiology

